Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro

Antibiotics
Maximilian StolteNahed El-Najjar

Abstract

Flucloxacillin (FLU), an isoxazolyl penicillin, is widely used for the treatment of different bacterial infections in intensive care units (ICU). Being highly bound to plasma proteins, FLU is prone to drug-drug interactions (DDI) when administered concurrently with other drugs. As FLU is binding to both Sudlow's site I and site II of human serum albumin (HSA), competitive and allosteric interactions with other drugs, highly bound to the same sites, seem conceivable. Knowledge about interaction(s) of FLU with the widely used anticancer agents paclitaxel (PAC), imatinib (IMA), and 5-fluorouracil (5-FU is scarce. The effects of the selected anticancer agents on the unbound fraction of FLU were evaluated in pooled plasma as well as in HSA and α-1-acid glycoprotein (AGP) samples, the second major drug carrier in plasma. FLU levels in spiked samples were analyzed by LC-MS/MS after ultrafiltration. Significant increase in FLU unbound fraction was observed when in combination with PAC and IMA and to a lesser extent with 5-FU. Furthermore, significant binding of FLU to AGP was observed. Collectively, this is the first study showing the binding of FLU to AGP as well as demonstrating a significant DDI between PAC/IMA/5-FU and FLU.

References

Nov 1, 1990·The Journal of Antimicrobial Chemotherapy·R Janknegt
Apr 1, 1989·Clinical Pharmacokinetics·R B Diasio, B E Harris
Jan 1, 1981·British Journal of Clinical Pharmacology·D J GreenblattR I Shader
Jan 1, 1994·Investigational New Drugs·P J LoehrerR T Chlebowski
Jan 23, 1993·BMJ : British Medical Journal·C K FairleyI Boyd
Jul 15, 1998·British Journal of Clinical Pharmacology·H L McLeod
Apr 4, 2001·The Journal of Biological Chemistry·I PetitpasS Curry
Sep 29, 2001·Journal of Internal Medicine·I BuajordetT Hilberg
Apr 25, 2002·Journal of Pediatric Hematology/oncology·Jean-Hugues DalleGuy Leverger
Aug 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A FeliciA Sparreboom
Feb 13, 2003·Journal of Clinical Monitoring and Computing·R RegenthalR Preiss
Jul 19, 2003·Journal of Chemotherapy·S S BunJ Catalin
Apr 15, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ibrahim A Alsarra, Mohammed N Alarifi
May 26, 2004·Bioorganic & Medicinal Chemistry·Lilianna Trynda-Lemiesz
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·David E NixEmily C Ferguson
Aug 27, 2005·Clinical Pharmacokinetics·Bin PengHorst Schran
Feb 14, 2006·Current Drug Metabolism·Sonu Sundd Singh
Mar 21, 2006·Journal of Pharmaceutical and Biomedical Analysis·Annette C MoserDavid S Hage
Apr 15, 2006·Mini Reviews in Medicinal Chemistry·Paolo AscenziMauro Fasano
Sep 30, 2006·Biochimica Et Biophysica Acta·Ilona FitosMiklós Simonyi
Jun 20, 2007·Antimicrobial Agents and Chemotherapy·Cornelia B LandersdorferFritz Sörgel
Jun 28, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Felix Kratz
Sep 10, 2008·Antimicrobial Agents and Chemotherapy·Stephan SchmidtHartmut Derendorf
Nov 27, 2008·British Journal of Clinical Pharmacology·Cornelia B LandersdorferFritz Sörgel
Feb 10, 2009·Critical Care : the Official Journal of the Critical Care Forum·Fabio Silvio TacconeJean-Louis Vincent
Feb 25, 2009·Critical Care Medicine·Jason A Roberts, Jeffrey Lipman
Jan 5, 2010·The Korean journal of laboratory medicine·Min-Jung KwonSoo-Youn Lee
Jun 10, 2010·The Journal of Antimicrobial Chemotherapy·Marta UlldemolinsJeffrey Lipman
Jun 1, 2009·Proteomics. Clinical Applications·Rosalind E JenkinsB Kevin Park
Dec 15, 2010·Clinical Pharmacokinetics·Marta UlldemolinsJeffrey Lipman
Mar 16, 2011·The Journal of Antimicrobial Chemotherapy·Cathrine McKenzie
May 4, 2011·Antimicrobial Agents and Chemotherapy·Markus A ZeitlingerUrsula Theuretzbacher
May 1, 2005·Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology·Paolo AscenziFabio Polticelli
Oct 25, 2012·Current Drug Metabolism·Zeqi Huang, Thao Ung
Nov 15, 2012·Clinical Pharmacokinetics·Jason A RobertsJeffrey Lipman
Jan 22, 2013·Médecine et maladies infectieuses·A JarfautR Herbrecht
Feb 16, 2013·British Journal of Cancer·R W F van LeeuwenF G A Jansman
Jul 25, 2013·Chemotherapy·A MouzonA Spinewine
Sep 21, 2013·Intensive Care Medicine·Andrew A UdyJeffrey Lipman
Jan 21, 2014·The Journal of Antimicrobial Chemotherapy·Gloria WongJason A Roberts

❮ Previous
Next ❯

Citations

Jul 11, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Eveline WallenburgRob Ter Heine

❮ Previous
Next ❯

Software Mentioned

Analyst

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society
Norma G Cuellar
BMJ : British Medical Journal
C Martyn
Emergency Medical Services
Jim Augustine
Pediatric Annals
Joseph R Hageman
© 2022 Meta ULC. All rights reserved